0001209191-18-058707.txt : 20181115
0001209191-18-058707.hdr.sgml : 20181115
20181115160429
ACCESSION NUMBER: 0001209191-18-058707
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181113
FILED AS OF DATE: 20181115
DATE AS OF CHANGE: 20181115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cole G Bradley
CENTRAL INDEX KEY: 0001337798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 181187290
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-13
0
0001131324
GENOMIC HEALTH INC
GHDX
0001337798
Cole G Bradley
301 PENOBSCOT DRIVE
REDWOOD CITY
CA
94063
0
1
0
0
CFO
Common Stock
2018-11-13
4
M
0
5000
17.18
A
50372
D
Common Stock
2018-11-13
4
M
0
3576
22.98
A
53948
D
Common Stock
2018-11-13
4
S
0
2817
78.2871
D
51131
D
Common Stock
2018-11-13
4
S
0
600
79.2967
D
50531
D
Common Stock
2018-11-13
4
S
0
1083
80.3184
D
49448
D
Common Stock
2018-11-13
4
S
0
500
81.602
D
48948
D
Common Stock
2018-11-13
4
S
0
1976
78.3428
D
46972
D
Common Stock
2018-11-13
4
S
0
900
80.2302
D
46072
D
Common Stock
2018-11-13
4
S
0
300
81.4567
D
45772
D
Common Stock
2018-11-13
4
S
0
400
79.1975
D
45372
D
Employee Stock Option (right to buy)
17.18
2018-11-13
4
M
0
5000
0.00
D
2020-02-18
Common Stock
5000
41471
D
Employee Stock Option (right to buy)
22.98
2018-11-13
4
M
0
3576
0.00
D
2021-01-27
Common Stock
3576
56424
D
Includes an aggregate of 16,534 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
These sales of common stock were effected pursuant to Rule 10b5-1 sales plans adopted by the reporting person on June 4, 2018 and August 23, 2018.
Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
Represents weighted average sale price. Actual sale prices ranged from $77.87 to $78.71.
Represents weighted average sale price. Actual sale prices ranged from $78.93 to $79.61.
Represents weighted average sale price. Actual sale prices ranged from $79.93 to $80.70.
Represents weighted average sale price. Actual sale prices ranged from $81.13 to $82.08.
Represents weighted average sale price. Actual sale prices ranged from $77.90 to $78.80.
Represents weighted average sale price. Actual sale prices ranged from $79.95 to $80.65.
Represents weighted average sale price. Actual sale prices ranged from $81.12 to $82.08.
Represents weighted average sale price. Actual sale prices ranged from $78.93 to $79.62.
The option became exercisable as to 25% of the shares on February 18, 2011, and became exercisable as to 1/48th of the shares each full month thereafter.
The option became exercisable as to 25% of the shares on January 27, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.
/s/ Jason W. Radford, Attorney-in-fact
2018-11-15